InvestorsHub Logo
Followers 32
Posts 12591
Boards Moderated 0
Alias Born 08/29/2012

Re: Dr Speculator Ninja post# 341553

Friday, 08/14/2020 5:00:20 PM

Friday, August 14, 2020 5:00:20 PM

Post# of 401487
Such a bland press release.

In 2015 when Elite reported record-breaking revenues, Nasrat put it in the title of the press release and also added his comments.

See here:

https://elite.irpass.com/profiles/investor/ResLibraryView.asp?ResLibraryID=78453&GoTopage=1&Category=2163&BzID=2258&t=1955&G=939

This press release contains neither.

Nobody knows last quarter was an all-time record-breaking revenue quarter and there is no "selling" of the company by Nasrat adding his comments.

I just don't understand how he continues to make all these mistakes.

Most shareholders or potential shareholders don't read the 10-Q.

They read the press release for specific info (record-breaking) and enthusiasm from the CEO (added statement), in which this contains neither as it has in the past.

Shaking my head.


NORTHVALE, NJ / ACCESSWIRE / August 14, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced results for the first quarter of fiscal year 2021 ended June 30, 2020 ("First Quarter").

Consolidated revenues for the First Quarter were $7.5 million, an increase of approximately 124% as compared to revenues for the comparable quarter of the prior fiscal year. The increase in revenues was largely attributed to revenues from generic extended release Adderall® which was launched during the First Quarter as well as increased sales of generic immediate release Adderall®, Isradipine and Phentermine during the First Quarter as compared to the comparable period for the prior fiscal year.






"Most people get interested in stocks when everyone else is. The time to get interested is when no one else is. You can't buy what is popular and do well." - Warren Buffett

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News